Prime Medicine Launches With $315m To Fund New Approach To Gene Editing

 
• By Alaric DeArment
  
DNA helix
Gene-editing company Prime Medicine launches with $315m in financing from two funding rounds • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Gene Therapies

More from Advanced Therapies